Oryzon Genomics announced today that the first patient has been dosed in a Phase I dose-finding clinical trial of iadademstat, Oryzon’s potent and selective LSD1 inhibitor, in combination with venet...
Read more
Oryzon Genomics S.A., compañía biofarmacéutica de fase clínica centrada en la epigenética para el desarrollo de terapias para enfermedades con importantes necesidades médicas no resueltas, se co...
Read more
Aimed at enhancing U.S. outreach, investor relations, corporate dialogue, and business development (BD) capabilities
Read more
Mineralys Therapeutics today announced that it has completed enrollment in the Explore-CKD Phase 2 trial evaluating the efficacy and safety of lorundrostat for the treatment of hypertension in subject...
Read more
Este evento bianual es un punto de encuentro destacado para investigadores portugueses y españoles especializados en la ciencia de los péptidos, y representa una oportunidad única para fomentar col...
Read more
Semaglutide has emerged as a groundbreaking therapy for managing type 2 diabetes, marketed under brand names like Ozempic. As a glucagon-like peptide-1 (GLP-1) receptor agonist, it significantly benef...
Read more
Oryzon Genomics, S.A, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the fou...
Read more
Oryzon Genomics a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give an upda...
Read more
Research is a basic instrument for combating epidemics/pandemics. Spain spends 1.49% of its GDP, well below the European average (2.3%).
Read more
The ICH, a non-profit international organization founded in 1990, developed the ICH guidelines as scientific consensus documents. The ICH guidelines full form stands for the International Council for ...
Read more
The pharmaceutical industry stands at a critical point. While saving lives through medicine, it’s also one of the most resource-intensive sectors on the planet, producing 55% more greenhouse gas emi...
Read more
The new compound is an inhibitor of soluble epoxide hydrolase (sEH), an enzyme involved in the regulation of several physiological processes, including inflammation and pain response. In the context o...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
